Hejin Jia

发表

Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia

Zhiqiang Wu, W. Han, Yao Wang, 2020, Journal of Hematology & Oncology.

Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation

Zhiqiang Wu, W. Han, Yao Wang, 2019, Journal of Hematology & Oncology.

Increased IFNγ+ T Cells Are Responsible for the Clinical Responses of Low-Dose DNA-Demethylating Agent Decitabine Antitumor Therapy

Q. Mei, W. Han, Lin Liu, 2017, Clinical Cancer Research.

CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma

Zhiqiang Wu, W. Han, Yao Wang, 2022, Blood advances.

Phase I Study of Chimeric Antigen Receptor–Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers

Zhiqiang Wu, W. Han, Yao Wang, 2017, Clinical Cancer Research.

Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer

W. Han, Yao Wang, Xiang Li, 2016, Science China Life Sciences.

Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment

Zhiqiang Wu, W. Han, Yao Wang, 2020, Cellular & Molecular Immunology.

Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer

W. Han, Yao Wang, Xiang Li, 2016, Science China Life Sciences.

Evaluation of 29 indicators for the prognosis of advanced non-small cell lung cancer with cytokine-induced killer cell therapy combined with chemotherapy

Yaping Tian, W. Han, Hejin Jia, 2016, Experimental and therapeutic medicine.

Relationship of serum polyunsaturated fatty acids with cytokines in colorectal cancer.

Pengjun Zhang, Hejin Jia, Chao-guang Jiang, 2016, World journal of gastroenterology.

Phase I Study of Chimeric Antigen Receptor–Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers

Zhiqiang Wu, W. Han, Yao Wang, 2017, Clinical Cancer Research.